COVID-19
-
June 12, 2020
TERAVOLT registry tracks outcomes of treatments among people with thoracic cancers sickened by COVID-19
New data from TERAVOLT, a global consortium that tracks outcomes of people with thoracic cancers affected by COVID-19, offers clues as to why they experienced a high death rate of 33% when the coronavirus swept across Europe. -
June 11, 2020
My daughter was born in the middle of the pandemic. She is going to get very tired of hearing that story when she’s older.
I can already picture Natalie rolling her eyes when she's 16. -
June 10, 2020
Children’s Hospital nurses support COVID colleagues: “Have a cup on us.”
A coffee gift card, along with a note of support -
June 10, 2020
Children’s Hospital expert offers COVID-19 “safe play” tips for parents
Are playdates OK? What are the risks to consider? -
June 9, 2020
VUMC’s REDCap serves pandemic response around the world
REDCap, the research data management tool created and powered by Vanderbilt University Medical Center, is serving extra duty as research teams and public health authorities around the world grapple with the COVID-19 pandemic. -
June 9, 2020
Vanderbilt, AstraZeneca collaborate on new COVID-19 antibody research
After evaluating the ability of more than 1,500 monoclonal antibodies to bind and neutralize the COVID-19 virus, SARS-CoV-2, in the laboratory, AstraZeneca signed an exclusive license to six candidate antibodies in Vanderbilt’s portfolio. -
June 4, 2020
Remdesivir helps reduce COVID-19 recovery time: study
The investigational antiviral drug remdesivir can shorten the time to recovery in adults hospitalized with COVID-19, according to preliminary results of a clinical trial published last month in The New England Journal of Medicine.